PSA-density does not appear to significantly improve its diagnostic performance.
Bi-parametric prostate MR (bp-MR) aids in detection of clinically significant prostate cancer (PCa), according to a study published in the European Journal of Radiology. Contrary to findings in the recent literature, PSA-D does not appear to significantly improve its diagnostic performance.
Researchers from Italy retrospectively analyzed 334 patients to evaluate the diagnostic performance of bp-MR, PSA-density (PSA-D) and their combination in biopsy-naïve patients.
All patients had undergone prostate MR on a 3T scanner. A total of 114 patients who underwent TRUS-biopsy within 30â¯days following MR with no previous prostate biopsies were included in the results. The researchers assessed three scenarios:
• Detection of lesions independently of ISUP score (ISUPâ¯≥â¯1)
• Detection of both intermediate and clinically significant lesions (ISUPâ¯≥â¯2)
• Detection of clinically significant lesions alone (ISUPâ¯≥â¯3).
The results showed that in all evaluated scenarios, bp-MR showed a significantly higher predictive power (AUCâ¯=â¯0.87 to 0.95) compared to the performance of PSA-D (AUCâ¯=â¯0.73 to 0.79), while their combination (AUCâ¯=â¯0.91 to 0.95) showed no statistically significant improvement compared to bp-MR alone.
The researchers concluded their results confirmed that bp-MR is a powerful tool in detection of clinically significant PCa. They also noted that contrary to findings in the recent literature, PSA-D does not appear to significantly improve its diagnostic performance.
FDA Clears Remote Scanning Support Platform for MRI, CT and PET/CT
March 25th 2024The multimodality system nCommand Lite reportedly facilitates real-time remote imaging guidance on scanning parameters and procedure assessments to licensed technologists for a variety of imaging modalities including CT and MRI.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Clears Mobile C-Arm Device that May Accelerate Fluoroscopic and 3D CT Imaging
March 21st 2024Offering ease of mobility and self-driving capabilities, the Ciartic Move C-arm device reportedly reduces the stress and potential for error associated with manual repositioning during intraoperative imaging with computed tomography and fluoroscopy.
Current Perspectives on Radiology Workforce Issues and Potential Solutions
March 14th 2024Emphasizing the gravity of the ongoing workforce shortage in radiology, these authors recommend a change agenda focusing on expanded numbers of residency positions, reassessment of educational pathways, maintaining a strong presence in hospital settings and practice level initiatives to reduce administrative burden and achieve appropriate reimbursement beyond RVU measurements.